共 50 条
Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: Training-HR study protocol
被引:1
|作者:
Palau, Patricia
[1
]
Nunez, Julio
[1
,2
]
Dominguez, Eloy
[1
,3
]
de la Espriella, Rafael
[1
]
Nunez, Gonzalo
[1
]
Flor, Cristina
[4
]
de Amo, Ivan
[1
]
Casana, Jose
[1
,4
]
Calatayud, Joaquin
[4
]
Ortega, Lucia
[5
]
Marin, Paloma
[5
]
Sanchis, Juan
[1
,2
]
Sanchis-Gomar, Fabian
[6
]
Lopez, Laura
[1
,4
]
机构:
[1] Univ Valencia, Hosp Clin Univ, Cardiol Dept, INCLIVA, Valencia, Spain
[2] CIBER Cardiovasc, Madrid, Spain
[3] Univ Jaume 1, Castellon De La Plana, Castellon, Spain
[4] Univ Valencia, Physiotherapy Dept, Valencia, Spain
[5] Univ Valencia, Dept Nursing, Valencia, Spain
[6] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA USA
关键词:
HFpEF;
Chronotropic incompetence;
Heart rate response;
PeakVO(2);
ASSOCIATION;
D O I:
10.1016/j.cpcardiol.2024.102839
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: Chronotropic incompetence (ChI) is linked with diminished exercise capacity in heart failure with preserved ejection fraction (HFpEF). Although exercise training has shown potential for improving functional capacity, the exercise modality associated with greater functional and chronotropic response (ChR) is not well-known. Additionally, how the ChR from different exercise modalities mediates functional improvement remains to be determined. This study aimed to evaluate the effect of three different exercise programs over current guideline recommendations on peak oxygen consumption (peakVO2) in patients with ChI HFpEF phenotype. Methods and results: In this randomized clinical trial, 80 stable symptomatic patients with HFpEF and ChI (NYHA class II-III/IV) are randomized (1:1:1:1) to receive: a) a 12-week program of supervised aerobic training (AT), b) AT and low to moderate-intensity strength training, c)AT and moderate to high-intensity strength training, or d) guideline-based physical activity and exercise recommendations. The primary endpoint is 12-week changes in peakVO(2). The secondary endpoints are 12-week changes in ChR, 12-week changes in quality of life, and how ChR changes mediate changes in peakVO(2). A mixed-effects model for repeated measures will be used to compare endpoint changes. The mean age is 75.1 +/- 7.2 years, and most patients are women (57.5 %) in New York Heart Association functional class II (68.7 %). The mean peakVO(2), percent of predicted peakVO(2), and ChR are 11.8 +/- 2.6 mL/kg/min, 67.2 +/- 14.7 %, and 0.39 +/- 0.16, respectively. No significant baseline clinical differences between arms are found. Conclusions: Training-HR will evaluate the effects of different exercise-based therapies on peakVO(2), ChR, and quality of life in patients with ChI HFpEF phenotype.
引用
收藏
页数:9
相关论文